Advisornet Financial’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20
| Closed | -$247 | – | 2525 |
|
|
2023
Q3 | $247 | Hold |
20
| – | – | ﹤0.01% | 2109 |
|
|
2023
Q2 | $246 | Hold |
20
| – | – | ﹤0.01% | 2188 |
|
|
2023
Q1 | $246 | Hold |
20
| – | – | ﹤0.01% | 2218 |
|
|
2022
Q4 | $229 | Hold |
20
| – | – | ﹤0.01% | 2191 |
|
|
2022
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 2089 |
|
|
2022
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 2234 |
|
|
2022
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 2280 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 2199 |
|
|
2021
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 2056 |
|
|
2021
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 1896 |
|
|
2021
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 1871 |
|
|
2020
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 1936 |
|
|
2020
Q3 | $0 | Buy |
+20
| New | – | ﹤0.01% | 1963 |
|